Monday, July 27, 2015

Inovio Pharmaceuticals Initiates Clinical Trial of INO-5150 DNA Immunotherapy for Prostate Cancer

“Your source for timely information on under-followed emerging growth companies”
Daily Notes:
7/27/2015












Top Story:









Inovio Pharmaceuticals Initiates Clinical Trial of INO-5150 DNA Immunotherapy for Prostate...
Inovio Pharmaceuticals Initiates Clinical Trial of INO-5150 DNA Immunotherapy for Prostate Cancer

No comments:

Post a Comment